Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Liquidia Corporation - Common Stock (NQ:LQDA)

16.72 +1.80 (+12.06%)
Streaming Delayed Price Updated: 3:21 PM EDT, Jun 2, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,971,953
Open 16.74
Bid (Size) 16.71 (7)
Ask (Size) 16.73 (2)
Prev. Close 14.92
Today's Range 15.95 - 17.88
52wk Range 8.260 - 19.41
Shares Outstanding 85,298,941
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Vera Therapeutics, Applied Digital, Kymera Therapeutics And Other Big Stocks Moving Higher On Monday
Via Benzinga
Liquidia Schedules First Commercial Shipment of YUTREPIA™ (treprostinil) Inhalation Powder for Patients with PAH and PH-ILD
From Liquidia Technologies, Inc.
Via GlobeNewswire

Performance

YTD
+38.2%
+38.2%
1 Month
+17.5%
+17.5%
3 Month
+5.2%
+5.2%
6 Month
+48.6%
+48.6%
1 Year
+36.0%
+36.0%

More News

Read More
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
These Analysts Boost Their Forecasts On Liquidia
Via Benzinga
Breaking Down Liquidia: 12 Analysts Share Their Views
Via Benzinga
Earnings Scheduled For May 8, 2025
Via Benzinga
Friday's after hours session: top gainers and losers
Via Chartmill
Liquidia Corporation to Present at the 2025 Jefferies Global Healthcare Conference
From Liquidia Technologies, Inc.
Via GlobeNewswire
Liquidia Scores FDA Nod For Lung Disease Drug Yutrepia, Faces Legal Challenge
Via Benzinga
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Liquidia Retail Buzz Surges After BofA Raises Price Target to $25 On Yutrepia FDA Nod
Via Stocktwits
Topics Intellectual Property
Exposures Intellectual Property Product Safety
U.S. FDA Approves Liquidia’s YUTREPIA™ (treprostinil) Inhalation Powder for Patients with Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated with Interstitial Lung Disease (PH-ILD)
From Liquidia Technologies, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Where Liquidia Stands With Analysts
Via Benzinga
Liquidia Corporation Provides Update on Litigation Filed by United Therapeutics
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Reports First Quarter 2025 Financial Results and Provides Corporate Update
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at BofA Securities 2025 Health Care Conference
From Liquidia Corporation
Via GlobeNewswire
District Court Dismisses Dispute Filed by United Therapeutics Against Liquidia
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Report First Quarter 2025 Financial Results on May 8, 2025
From Liquidia Corporation
Via GlobeNewswire
Breaking Down Liquidia: 4 Analysts Share Their Views
Via Benzinga
UPDATE – Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
From Liquidia Corporation
Via GlobeNewswire
Liquidia Corporation Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA™ (treprostinil) Inhalation Powder
From Liquidia Corporation
Via GlobeNewswire
Liquidia Announces Poster Presentations at the American Thoracic Society (ATS) 2025 International Conference
From Liquidia Corporation
Via GlobeNewswire
What 4 Analyst Ratings Have To Say About Liquidia
Via Benzinga
Tesla To $450? Here Are 10 Top Analyst Forecasts For Thursday
Via Benzinga

Frequently Asked Questions

Is Liquidia Corporation - Common Stock publicly traded?
Yes, Liquidia Corporation - Common Stock is publicly traded.
What exchange does Liquidia Corporation - Common Stock trade on?
Liquidia Corporation - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Liquidia Corporation - Common Stock?
The ticker symbol for Liquidia Corporation - Common Stock is LQDA on the Nasdaq Stock Market
What is the current price of Liquidia Corporation - Common Stock?
The current price of Liquidia Corporation - Common Stock is 16.72
When was Liquidia Corporation - Common Stock last traded?
The last trade of Liquidia Corporation - Common Stock was at 06/02/25 03:21 PM ET
What is the market capitalization of Liquidia Corporation - Common Stock?
The market capitalization of Liquidia Corporation - Common Stock is 1.43B
How many shares of Liquidia Corporation - Common Stock are outstanding?
Liquidia Corporation - Common Stock has 1B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.